We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Double-bridged Peptide Tailored to Bind Tightly to Disease Targets of Interest

News   May 02, 2018 | Original story from Ecole Polytechnique Fédérale de Lausanne

 
Double-bridged Peptide Tailored to Bind Tightly to Disease Targets of Interest

A model of a double-bridged peptide (the peptide in light blue, the two bridges in yellow). The background of the figures shows many examples of skeletons (also named "scaffolds" or "backbones") of double-bridged peptides. Credit: C. Heinis/EPFL

 
 
 

RELATED ARTICLES

Broadly Acting Antibodies Found in Blood of Ebola Survivors

News

Scientists have discovered a set of powerful, broadly neutralizing antibodies in the blood of Ebola survivors. In animal studies, two of these antibodies provided substantial protection against disease caused by the three species known to cause fatal human illness.

READ MORE

Fetal Gene Therapy Prevents Lethal Neurodegenerative Disease

News

Researchers have successfully prevented the development of a fatal neurodegenerative disorder, Gaucher disease, using fetal gene therapy, in mice. The study highlights the potential of using this approach to combat lethal neurodegenerative diseases affecting newborns.

READ MORE

Testosterone Effective at Combating Cachexia in Cancer Patients

News

Many cancer patients suffer from a loss of body mass known as cachexia. A new study shows that the hormone testosterone is effective at combatting cachexia in cancer patients and improving quality of life.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE